Low intensity shockwave therapy in combination with phosphodiesterase-5 inhibitors is an effective and safe treatment option in patients with vasculogenic ED who are PDE5i non-responders: a multicenter single-arm clinical trial
Alessandro Palmieri, Davide Arcaniolo, Fabrizio Palumbo, Paolo Verze, Giovanni Liguori, Nicola Mondaini, Marco Falcone, Fabrizio Ildefonso Scroppo, Andrea Salonia, Tommaso Cai, SIA-Low intensity shock wave for Erectile Dysfunction (LED) Study Group, Andrea Cocci, Marco De Sio, D. Di Trapani, Attilio Guerani, Emilio Italiano, Francesco Marone, Irene Tamanini, M. Timpano, Alessandro Zucchi
Topics & Concepts
MedicineErectile dysfunctionQuality of life (healthcare)cGMP-specific phosphodiesterase type 5UrologyProspective cohort studyExtracorporeal shockwave therapyInternal medicineCombination therapyCohortOutpatient clinicSurgeryNursingSexual function and dysfunction studiesHormonal and reproductive studiesUrinary Bladder and Prostate Research